Displaying drugs 7176 - 7200 of 13635 in total
AB192
AB192 is a DPP IV enzymatic activity inhibitor.
Experimental
Matched Description: … AB192 is a DPP IV enzymatic activity inhibitor. …
CX516
Investigational
Bromelains
Bromelain is a protease enzyme derived from the stems of pineapples that is composed of a mixture of different thiol endopeptidases and other components like phosphatase, glucosidase, peroxidase, cellulase, escharase, and several protease inhibitors . It works by selectively inhibiting the biosynthesis of proinflammatory prostaglandins and also has analgesic properties,...
Investigational
Matched Description: … Bromelain is a protease enzyme derived from the stems of pineapples that is composed of a mixture of ... It is considered as a safe food supplement. ... Bromelain holds potential therapeutic effect as a treatment of conditions including angina pectoris, …
Matched Categories: … Preparations for Treatment of Wounds and Ulcers …
Matched Categories: … Preparations for Treatment of Wounds and Ulcers …
Methopterin
Methopterin is thought to have effects on osteoclasts and to inhibit inflammatory bone destruction.
Investigational
Sebacic acid
Experimental
Imidazole
Experimental
Investigational
Matched Categories: … Thromboxane-A Synthase, antagonists & inhibitors …
Ioglicic acid
Experimental
alpha-Lactalbumin
alpha-Lactalbumin is under investigation in clinical trial NCT02082418 (Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly).
Investigational
Matched Description: … Intake on Metabolic and Cognitive Functions in Elderly). ... alpha-Lactalbumin is under investigation in clinical trial NCT02082418 (Effects of Alpha-lactalbumin …
meso-Tartaric acid
Experimental
AV-412
Investigational
Chlormidazole
Experimental
Matched Categories: … Antifungals for Topical Use ... Antifungals for Dermatological Use …
Carbuterol
Experimental
Matched Categories: … Adrenergics for Systemic Use ... Drugs for Obstructive Airway Diseases …
PPI-2458
PPI-2458 represents a potentially new and important addition to the growing list of therapeutics aimed at specific molecular oncology targets. PPI-2458 is a novel, proprietary molecule belonging to the fumagillin class of compounds that specifically targets the MetAP-2 enzyme. This class of compounds has been shown to prevent both abnormal...
Investigational
Matched Description: … PPI-2458 represents a potentially new and important addition to the growing list of therapeutics aimed ... PPI-2458 is a novel, proprietary molecule belonging to the fumagillin class of compounds that specifically ... In preclinical studies to date, PPI-2458 has demonstrated the potent pharmacologic activity of this class …
Malonic acid
Experimental
Cilazaprilat
Experimental
Matched Iupac: … (1S,9S)-9-{[(1S)-1-carboxy-3-phenylpropyl]amino}-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine- …
Sagopilone
Sagopilone has been used in trials studying the treatment of Melanoma, Neoplasms, CNS Disease, Breast Cancer, and Breast Neoplasms, among others. It is a so-called fully synthetic epothilone and is the first such compound to be in clinical development to combat several forms of cancer. Epothilones are 16-member ring macrolides...
Investigational
Matched Description: … It is a so-called fully synthetic epothilone and is the first such compound to be in clinical development ... Epothilones are 16-member ring macrolides with antimicrotubule activity that share a similar mechanism ... multidrug-resistant and paclitaxel-resistant tumor cell lines in vitro and in vivo. …
CX501
Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of the oesophagus. It is developed by Cellerix and is in phase I of clinical trials.
Investigational
Matched Description: … It is developed by Cellerix and is in phase I of clinical trials. ... Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction …
1-Naphthoxyacetic acid
Experimental
Ditazole
Ditazole is a non-steroidal anti-inflammatory drug (NSAID). Ditazole's analgesic and antipyretic effects are similar to phenylbutazone. Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade name Ageroplas.
Experimental
Withdrawn
Matched Description: … Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade ... Ditazole is a non-steroidal anti-inflammatory drug (NSAID). …
Scriptaid
Scriptaid is a histone deacetylase (HDAC) inhibitor researched for its anti-tumor properties.
Investigational
Matched Description: … Scriptaid is a histone deacetylase (HDAC) inhibitor researched for its anti-tumor properties. …
Axalimogene filolisbac
Axalimogene filolisbac is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
Investigational
Matched Description: … Axalimogene filolisbac is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects …
Mevalonic acid
Experimental
Amiselimod
Experimental
DP-b99
DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment of stroke, head trauma and neurological damage associated with coronary artery bypass graft.
Investigational
Matched Description: … ,N,N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment ... DP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N …
Displaying drugs 7176 - 7200 of 13635 in total